https://orcid.org/0009-0006-5954-9761
References
- Thein SL. Genetic basis and genetic modifiers of β-thalassemia and sickle cell disease[J/OL]. Adv Exp Med Biol. 2017;1013:27–57. doi:10.1007/978-1-4939-7299-9_2
- Jiang LX, Fan YH, Yi W, et al. Identification of 2 two rare cases of β0-thalassemia mutation odon41(-C)[J]. Chin J Eugenics Genet. 2018;26(11):14–17.
- Rund D, Rachmilewitz E. Beta-thalassemia[J]. N Engl J Med. 2005;353(11):1135–1146. doi:10.1056/NEJMra050436
- Cappellini MD, Motta I. New therapeutic targets in transfusion-dependent and -independent thalassemia[J/OL]. Hematology Am Soc Hematol Educ Program. 2017;2017(1):278–283. doi:10.1182/asheducation-2017.1.278
- Sagar CS, Kumar R, Sharma DC. 等. DNA damage: beta zero versus beta plus thalassemia[J/OL]. Ann Hum Biol. 2015;42(6):585–588. doi:10.3109/03014460.2014.990921
- Origa R. β-Thalassemia[J/OL]. Genet Med. Official J Am College Med Genet. 2017;19(6):609–619. doi:10.1038/gim.2016.173
- Muncie HL, Campbell J. Alpha and beta thalassemia[J]. Am Fam Physician. 2009;80(4):339–344.
- Chen DY, Sun XF. Progress in the study of the modifying role of iron metabolism on the phenotype of β-thalassemia[J]. Chin J Med Genet. 2021;38(1):27–31.
- Xinh PT, Chuong HQ, Hant T. 等. Spectrum of HBB gene mutations among 696 β–thalassemia patients and carriers in Southern Vietnam[J/OL]. Mol Biol Rep. 2022;49(4):2601–2606. doi:10.1007/s11033-021-07062-w
- Panyasai S, Jaiping K, Pornprasert S. Elevated Hb A₂ levels in a patient with a compound heterozygosity for the (β+) -31 (A > G) and (β0) Codon 17 (A > T) mutations together with a single α-globin gene[J/OL]. Hemoglobin. 2015;39(4):292–295. doi:10.3109/03630269.2015.1047513
- Khandros E, Kwiatkowski JL. Beta thalassemia: monitoring and new treatment approaches[J/OL]. Hematol Oncol Clin North Am. 2019;33(3):339–353. doi:10.1016/j.hoc.2019.01.003
- Shang X, Wu X, Zhang X, et al. Clinical practice guidelines for beta-thalassemia][J/OL]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2020;37(3):243–251. doi:10.3760/cma.j.issn.1003-9406.2020.03.004
- La Nasa G, Vacca A, Littera R, et al. What unrelated hematopoietic stem cell transplantation in thalassemia taught us about transplant immunogenetics[J/OL]. Mediterr J Hematol Infect Dis. 2016;8(1):e2016048. doi:10.4084/MJHID.2016.048
- Michlitsch JG, Walters MC. Recent advances in bone marrow transplantation in hemoglobinopathies[J/OL]. Curr Mol Med. 2008;8(7):675–689. doi:10.2174/156652408786241393
- Horvei P, Mackenzie T, Kharbanda S. Advances in the management of α-thalassemia major: reasons to be optimistic[J/OL]. Hematology Am Soc Hematol Educ Program. 2021;2021(1):592–599. doi:10.1182/hematology.2021000295
- Zhu XJ, Liu YP, Liu RY, et al. Analysis of prenatal genetic diagnosis of fetal thalassemia in homozygous α-thalassemia couples in Huizhou[J]. Chin J Child Health. 2015;23(1):15–17.
- Li XY, Chen SQ, Xu LH, et al. Clinical diagnosis and genetic testing in a case of intermediate β-thalassemia[J]. Chin J Pediatric Hematol Oncol. 2014;19(3):138–142.